New data published today in the American Journal of Infection Control (AJIC) highlight major barriers impacting healthcare workers' ability to perform successful central line-associated bloodstream infection (CLABSI) surveillance ...
Apr 28, 2022
0
4
Antiretroviral therapy has made HIV a manageable condition, but it does not eliminate the virus from the body—and most regimens are expensive and require a pill every day, for the rest of the patient's life.
Apr 19, 2022
0
28
Researchers at Children's Hospital of Philadelphia (CHOP) have shown that a targeted treatment they developed is effective at controlling blood sugar in patients with hyperinsulinism (HI), a genetic disease in which the pancreas ...
Apr 13, 2022
0
16
You've probably seen an infusion pump, even though the name might make it sound like a mysterious piece of medical technology.
Mar 21, 2022
0
9
For nonhospitalized patients with symptomatic mild-to-moderate COVID-19 and a high risk for progression, risk for all-cause hospitalization or death is reduced with sotrovimab versus placebo, according to a study published ...
Mar 18, 2022
0
12
(HealthDay)—Antibody infusions help keep high-risk COVID-19 patients out of the hospital, but getting the therapy can be a challenge. One U.S. health system has found a creative way to address the problem: home infusions ...
Oct 21, 2021
0
21
One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite. The small, carefully monitored ...
Aug 12, 2021
0
6
Critically ill COVID-19 patients treated with non-altered stem cells from umbilical cord connective tissue were more than twice as likely to survive as those who did not have the treatment, according to a study published ...
Jun 8, 2021
0
0
Researchers hope to save significant time, money and resources in Australian hospital wards, with findings from a new University of Queensland-led study.
May 7, 2021
0
5
The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer that has progressed after treatment ...
Apr 26, 2021
0
3
